Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-08-20 5:23 pm Sale | 2025-08-18 | 13D | MBX Biosciences, Inc. Common Stock MBX | Frazier Life Sciences Public Fund, L.P. | 4,557,097 13.600% | -1,428,250 (-23.86%) | Filing History |
| 2025-08-20 5:20 pm Sale | 2025-08-18 | 13D | KalVista Pharmaceuticals, Inc. KALV | Frazier Life Sciences Public Fund, L.P. | 2,400,276 4.800% | -2,487,591 (-50.89%) | Filing History |
| 2025-08-20 5:18 pm Sale | 2025-08-18 | 13D | Phathom Pharmaceuticals, Inc. PHAT | Frazier Life Sciences Public Fund, L.P. | 5,985,327 8.600% | -8,444,663 (-58.52%) | Filing History |
| 2025-08-14 1:47 pm Purchase | 2025-06-30 | 13G | Xilio Therapeutics, Inc. XLO | Frazier Life Sciences Public Fund, L.P. | 8,141,017 9.900% | 2,393,824 (+41.65%) | Filing History |
| 2025-08-14 1:46 pm Sale | 2025-06-30 | 13G | Jade Biosciences, Inc. JBIO | Frazier Life Sciences Public Fund, L.P. | 1,340,703 4.200% | -431,413 (-24.34%) | Filing History |
| 2025-08-14 1:44 pm Sale | 2025-06-30 | 13G | Aura Biosciences, Inc. AURA | Frazier Life Sciences Public Fund, L.P. | 3,113,550 5.000% | -3,202,128 (-50.70%) | Filing History |
| 2025-08-14 1:43 pm Sale | 2025-06-30 | 13G | Maze Therapeutics, Inc. MAZE | Frazier Life Sciences Public Fund, L.P. | 3,352,915 7.700% | -1,098,424 (-24.68%) | Filing History |
| 2025-08-14 1:41 pm Sale | 2025-06-30 | 13G | Palvella Therapeutics, Inc. PVLA | Frazier Life Sciences Public Fund, L.P. | 545,504 4.900% | -144,508 (-20.94%) | Filing History |
| 2025-08-14 1:40 pm Sale | 2025-06-30 | 13G | Lexeo Therapeutics, Inc. Common Stock LXEO | Frazier Life Sciences Public Fund, L.P. | 3,073,467 5.700% | -2,427,345 (-44.13%) | Filing History |
| 2025-08-14 1:39 pm Sale | 2025-06-30 | 13G | Mereo BioPharma Group plc MREO | Frazier Life Sciences Public Fund, L.P. | 32,430,690 4.100% | -7,918,625 (-19.63%) | Filing History |
| 2025-08-14 1:12 pm Sale | 2025-06-30 | 13G | Savara Inc. SVRA | Frazier Life Sciences Public Fund, L.P. | 6,745,296 3.900% | -4,717,005 (-41.15%) | Filing History |
| 2025-08-14 1:11 pm Sale | 2025-06-30 | 13G | Disc Medicine, Inc. IRON | Frazier Life Sciences Public Fund, L.P. | 1,026,489 3.000% | -728,345 (-41.51%) | Filing History |
| 2025-08-14 1:10 pm Sale | 2025-06-30 | 13G | Erasca, Inc. ERAS | Frazier Life Sciences Public Fund, L.P. | 15,038,753 5.300% | -7,537,098 (-33.39%) | Filing History |
| 2025-08-14 1:08 pm Sale | 2025-07-23 | 13G | Elevation Oncology, Inc. ELEV | Frazier Life Sciences Public Fund, L.P. | 0 0.000% | -5,993,579 (Position Closed) | Filing History |
| 2025-08-14 1:04 pm Purchase | 2025-08-12 | 13G | Adverum Biotechnologies, Inc. ADVM | Frazier Life Sciences Public Fund, L.P. | 1,129,057 5.400% | 1,129,057 (New Position) | Filing History |
| 2025-08-14 1:02 pm Sale | 2025-06-30 | 13G | MacroGenics, Inc. MGNX | Frazier Life Sciences Public Fund, L.P. | 1,549,193 2.500% | -1,626,472 (-51.22%) | Filing History |
| 2025-06-12 4:55 pm Purchase | 2025-06-05 | 13G | Xilio Therapeutics, Inc. XLO | Frazier Life Sciences Public Fund, L.P. | 5,747,193 9.900% | 5,747,193 (New Position) | Filing History |
| 2025-06-04 4:51 pm Purchase | 2025-05-28 | 13G | Lexeo Therapeutics, Inc. Common Stock LXEO | Frazier Life Sciences Public Fund, L.P. | 5,500,812 9.900% | 5,500,812 (New Position) | Filing History |
| 2025-05-23 4:07 pm Purchase | 2025-05-16 | 13G | Aura Biosciences, Inc. AURA | Frazier Life Sciences Public Fund, L.P. | 6,315,678 9.900% | 6,315,678 (New Position) | Filing History |
| 2025-05-15 09:55 am Sale | 2025-03-31 | 13G | Trevi Therapeutics, Inc. TRVI | Frazier Life Sciences Public Fund, L.P. | 10,259,409 10.600% | -405,365 (-3.80%) | Filing History |